Trump administration slashes billions from biomedical research overheads

The Trump administration’s decision to reduce billions in overhead costs from biomedical research grants has stirred debate, with supporters arguing for financial efficiency and critics warning of severe consequences for medical advancements.

The cuts primarily affect indirect costs—funds typically allocated for essential expenses like laboratory maintenance, equipment, and administrative support.

By capping these costs at 15%, down from the previous average of 30%, the administration claims to save around $4 billion while directing more funds toward actual research.

However, scientists and research institutions argue that these reductions could cripple medical breakthroughs, slow innovation, and force some institutions to scale back operations or shut down entirely.

Government officials defending the move, including members of the Department of Government Efficiency, suggest that universities have been misusing research funds.

Meanwhile, the Association of American Medical Colleges and other advocacy groups emphasize the risks, highlighting how reduced funding could delay life-saving treatments, vaccines, and groundbreaking discoveries.

The policy aligns with recommendations from conservative think tanks advocating for stricter limits on government-funded research overheads.

The post Trump administration slashes billions from biomedical research overheads appeared first on MyNewsGh.